U.S. FDA notifies Amazon over sale of weight-loss products with harmful ingredients

FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly

(Reuters) – The U.S Food and Drug Administration (FDA) notified Amazon.com Inc over the sale of sexual enhancement and weight-loss products that had potentially harmful drug ingredients, in a letter addressed to the company’s new boss Andy Jassy.

Amazon was not immediately available for a comment.

Source: Read Full Article

Related posts:
  1. U.S. FDA approves Novo Nordisk's semaglutide as obesity treatment
  2. U.S. FDA narrows use of Biogen Alzheimer's drug; shares rise
  3. Tennessee asks top U.S. court to reinstate two-day waiting period for abortions
  4. India bans exports of Remdesivir drug as new COVID-19 cases hit another record